Preprint · CC-BY
via OpenAlex
Familial parkinsonism with synuclein pathology
Rejko Krüger, Wilfried Kuhn, Klaus Leonhard Leenders, Reiner Sprengelmeyer, T. Müller, Dirk Woitalla, Axel T. Portman, Ralph Paul Maguire, L. Veenma, Uwe Schröder, Ludger J. Schöls, Jörg T. Epplen, Olaf Rieß, H. Przuntek
Neurology · 2001 · ▲ 153 citations
Abstract
BACKGROUND: The authors identified the second known mutation in the alpha-synuclein(SNCA) gene, an alanine-to-proline exchange in amino acid position 30 (A30P), that cosegregates with the disease in one German family with autosomal dominantly inherited parkinsonism (ADP). The authors studied carriers of the A30P mutation to compare the phenotype of this mutation with idiopathic PD (IPD) and to assess nigrostriatal dopaminergic function in symptomatic and preclinical mutation carriers. METHODS: The pedigree of the A30P family spans five generations with five affected individuals. The authors performed detailed neurologic examinations followed by mutation analysis in 11 living individuals. In three mutation carriers, two individuals with definite PD and one person at risk for PD, they used L-[18]F-fluoro-3,4-dihydroxyphenylalanine (F-DOPA), [11]C-raclopride (RAC), and [18]F-fluorodeoxyglucose (FDG) PET to investigate presynaptic dopaminergic function, dopamine D2 receptors, and cerebral energy metabolism. The authors studied the cognitive functions of carriers of the A30P mutation using neuropsychological screening. RESULTS: PET studies revealed striatal presynaptic dopaminergic alterations consistent with sporadic IPD in two affected family members and no evidence for nigrostriatal dopaminergic dysfunction in one presymptomatic mutation carrier. Neuropsychological testing in four mutation carriers provided evidence for cognitive impairment as a frequent and early symptom of the A30P mutation; this is also supported by regional cerebral energy metabolism alterations in the clinically presymptomatic subject. CONCLUSIONS: The phenotype of the A30P mutation in the SNCA gene is similar to that of sporadic IPD, including a high variability of the age at disease onset, ranging from 54 to 76 years. The follow-up of presymptomatic carriers of the A30P mutation may give insight into preclinical disease stages and early manifestations of PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1212/wnl.56.10.1355
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Krüger, R., Kuhn, W., Leenders, K.L., Sprengelmeyer, R., Müller, T., Woitalla, D., Portman, A.T., Maguire, R.P., Veenma, L., Schröder, U., Schöls, L.J., Epplen, J.T., Rieß, O., & Przuntek, H. (2001). Familial parkinsonism with synuclein pathology. <em>Neurology</em>. https://doi.org/10.1212/wnl.56.10.1355
Vancouver
Krüger R, Kuhn W, Leenders KL, Sprengelmeyer R, Müller T, Woitalla D, et al. Familial parkinsonism with synuclein pathology. Neurology. 2001. doi:10.1212/wnl.56.10.1355.
BibTeX
@unpublished{rejko2001Famili,
title = {Familial parkinsonism with synuclein pathology},
author = {Rejko Krüger and Wilfried Kuhn and Klaus Leonhard Leenders and Reiner Sprengelmeyer and T. Müller and Dirk Woitalla and Axel T. Portman and Ralph Paul Maguire and L. Veenma and Uwe Schröder and Ludger J. Schöls and Jörg T. Epplen and Olaf Rieß and H. Przuntek},
journal = {Neurology},
year = {2001},
doi = {10.1212/wnl.56.10.1355},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Colorado, Denver 2016
Open access · US-GOV
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
Judit Pich Martínez 2015
Open access · US-GOV
Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease: 18F-Florbetaben Positron Emission Tomography Study
PLoS ONE 2013
Open access · CC-BY
Accelerated Cell Aging in Female APOE-ε4 Carriers: Implications for Hormone Therapy Use
Patrick Lao 2017
Open access · US-GOV
Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240
Advances in Geriatrics 2014
Open access · CC-BY
Oxidative Stress and Proteostasis Network: Culprit and Casualty of Alzheimer’s-Like Neurodegeneration
Texas ScholarWorks (Texas Digital Library) 2014
Preprint · OA